Hassan Bousbaa
AuthID: R-000-5PY
41
TITLE: Prenylated Chalcone 2 Acts as an Antimitotic Agent and Enhances the Chemosensitivity of Tumor Cells to Paclitaxel Full Text
AUTHORS: Joana Fonseca; Sandra Marques; Patricia M A Silva; Pedro Brandao; Honorina Cidade ; Madalena M Pinto; Hassan Bousbaa;
PUBLISHED: 2016, SOURCE: MOLECULES, VOLUME: 21, ISSUE: 8
AUTHORS: Joana Fonseca; Sandra Marques; Patricia M A Silva; Pedro Brandao; Honorina Cidade ; Madalena M Pinto; Hassan Bousbaa;
PUBLISHED: 2016, SOURCE: MOLECULES, VOLUME: 21, ISSUE: 8
42
TITLE: Prognostic significance of CD44v6, p63, podoplanin and MMP-9 in oral squamous cell carcinomas Full Text
AUTHORS: Monteiro, LS; Delgado, ML; Ricardo, S; do Amaral, B; Salazar, F; Pacheco, JJ; Lopes, CA; Bousbaa, H; Warnakulasuryia, S;
PUBLISHED: 2016, SOURCE: ORAL DISEASES, VOLUME: 22, ISSUE: 4
AUTHORS: Monteiro, LS; Delgado, ML; Ricardo, S; do Amaral, B; Salazar, F; Pacheco, JJ; Lopes, CA; Bousbaa, H; Warnakulasuryia, S;
PUBLISHED: 2016, SOURCE: ORAL DISEASES, VOLUME: 22, ISSUE: 4
43
TITLE: Targeting the Spindle Assembly Checkpoint for Breast Cancer Treatment
AUTHORS: Sandra Marques; Joana Fonseca; Patricia M A Silva; Hassan Bousbaa;
PUBLISHED: 2015, SOURCE: CURRENT CANCER DRUG TARGETS, VOLUME: 15, ISSUE: 4
AUTHORS: Sandra Marques; Joana Fonseca; Patricia M A Silva; Hassan Bousbaa;
PUBLISHED: 2015, SOURCE: CURRENT CANCER DRUG TARGETS, VOLUME: 15, ISSUE: 4
INDEXED IN: 
Scopus 
WOS
Scopus WOS IN MY: 
ORCID
ORCID44
TITLE: Clinicopathologic significance of BubR1 and Mad2 overexpression in oral cancer Full Text
AUTHORS: Teixeira, JH; Silva, PMA; Faria, J; Ferreira, I; Duarte, P; Delgado, ML; Queiros, O; Moreira, R; Barbosa, J; Lopes, CA; Amaral, JS; Monteiro, LS; Bousbaa, H;
PUBLISHED: 2015, SOURCE: ORAL DISEASES, VOLUME: 21, ISSUE: 6
AUTHORS: Teixeira, JH; Silva, PMA; Faria, J; Ferreira, I; Duarte, P; Delgado, ML; Queiros, O; Moreira, R; Barbosa, J; Lopes, CA; Amaral, JS; Monteiro, LS; Bousbaa, H;
PUBLISHED: 2015, SOURCE: ORAL DISEASES, VOLUME: 21, ISSUE: 6
45
TITLE: Clinicopathologic significance of BubR1 and Mad2 overexpression in oral cancer
AUTHORS: Teixeira, JH; Silva, PMA; Faria, J; Ferreira, I; Duarte, P; Delgado, ML; Queiros, O; Moreira, R; Barbosa, J; Lopes, CA; do Amaral, JB; Monteiro, LS; Bousbaa, H;
PUBLISHED: 2015, SOURCE: Oral Diseases, VOLUME: 21, ISSUE: 6
AUTHORS: Teixeira, JH; Silva, PMA; Faria, J; Ferreira, I; Duarte, P; Delgado, ML; Queiros, O; Moreira, R; Barbosa, J; Lopes, CA; do Amaral, JB; Monteiro, LS; Bousbaa, H;
PUBLISHED: 2015, SOURCE: Oral Diseases, VOLUME: 21, ISSUE: 6
INDEXED IN: Scopus
Scopus IN MY: ORCID
ORCID46
TITLE: Non-Small Cell Lung Carcinoma: An Overview on Targeted Therapy
AUTHORS: Nascimento, AV; Bousbaa, H; Ferreira, D ; Sarmento, B ;
PUBLISHED: 2015, SOURCE: CURRENT DRUG TARGETS, VOLUME: 16, ISSUE: 13
AUTHORS: Nascimento, AV; Bousbaa, H; Ferreira, D ; Sarmento, B ;
PUBLISHED: 2015, SOURCE: CURRENT DRUG TARGETS, VOLUME: 16, ISSUE: 13
47
TITLE: Co-silencing of human Bub3 and dynein highlights an antagonistic relationship in regulating kinetochore-microtubule attachments Full Text
AUTHORS: Patricia M A Silva; Alvaro A Tavares; Hassan Bousbaa;
PUBLISHED: 2015, SOURCE: FEBS LETTERS, VOLUME: 589, ISSUE: 23
AUTHORS: Patricia M A Silva; Alvaro A Tavares; Hassan Bousbaa;
PUBLISHED: 2015, SOURCE: FEBS LETTERS, VOLUME: 589, ISSUE: 23
48
TITLE: Targeting the Spindle Assembly Checkpoint for Breast Cancer Treatment
AUTHORS: Sandra Marques; Joana Fonseca; Patricia Silva; Hassan Bousbaa;
PUBLISHED: 2015, SOURCE: Current Cancer Drug Targets - CCDT, VOLUME: 15, ISSUE: 4
AUTHORS: Sandra Marques; Joana Fonseca; Patricia Silva; Hassan Bousbaa;
PUBLISHED: 2015, SOURCE: Current Cancer Drug Targets - CCDT, VOLUME: 15, ISSUE: 4
49
TITLE: Combinatorial-Designed Epidermal Growth Factor Receptor-Targeted Chitosan Nanoparticles for Encapsulation and Delivery of Lipid-Modified Platinum Derivatives in Wild-Type and Resistant Non-Small-Cell Lung Cancer Cells Full Text
AUTHORS: Ana Vanessa Nascimento; Arnit Singh; Hassan Bousbaa; Domingos Ferreira ; Bruno Sarmento ; Mansoor M Amiji;
PUBLISHED: 2015, SOURCE: MOLECULAR PHARMACEUTICS, VOLUME: 12, ISSUE: 12
AUTHORS: Ana Vanessa Nascimento; Arnit Singh; Hassan Bousbaa; Domingos Ferreira ; Bruno Sarmento ; Mansoor M Amiji;
PUBLISHED: 2015, SOURCE: MOLECULAR PHARMACEUTICS, VOLUME: 12, ISSUE: 12
50
TITLE: New chiral derivatives of xanthones: Synthesis and investigation of enantioselectivity as inhibitors of growth of human tumor cell lines Full Text
AUTHORS: Fernandes, C ; Masawang, K; Tiritan, ME ; Sousa, E ; de Lima, V; Afonso, C ; Bousbaa, H; Sudprasert, W; Pedro, M; Pinto, MM ;
PUBLISHED: 2014, SOURCE: BIOORGANIC & MEDICINAL CHEMISTRY, VOLUME: 22, ISSUE: 3
AUTHORS: Fernandes, C ; Masawang, K; Tiritan, ME ; Sousa, E ; de Lima, V; Afonso, C ; Bousbaa, H; Sudprasert, W; Pedro, M; Pinto, MM ;
PUBLISHED: 2014, SOURCE: BIOORGANIC & MEDICINAL CHEMISTRY, VOLUME: 22, ISSUE: 3
